Table 3 Demographic characteristics of the NoV-AGE patients
AGE patients | NoV-AGE patients | Detection rate [%, (95% CI)] | χ2 | P value | |
|---|---|---|---|---|---|
N (%) | N (%) | ||||
Gender | |||||
Male | 3084 (52.0) | 743 (54.5) | 24.1 (22.6–25.6) | 4.36 | 0.037 |
Female | 2843 (48.0) | 620 (45.5) | 21.8 (20.3–23.3) | ||
Age group | |||||
< 5 year | 922 (15.6) | 189 (13.9) | 20.5 (17.9–23.1) | 41.93 | < 0.001 |
5–14 year | 530 (8.9) | 78 (5.7) | 14.7 (11.7–17.7) | ||
15–24 year | 451 (7.6) | 99 (7.3) | 22.0 (18.1–25.8) | ||
25–64 year | 3282 (55.4) | 847 (62.1) | 25.8 (24.3–27.3) | ||
≥ 65 year | 742 (12.5) | 150 (11.0) | 20.2 (17.3–23.1) | ||
Total | 5927 | 1363 | 22.3 | ||